Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 205
Selected: 0
NCT IDTitle
NCT01442987Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
NCT01037543Safety and PK of HM10460A (HNK460) in Healthy Adult Japanese and Caucasian Subjects
NCT05656092A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
NCT03228277Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA
NCT01548157Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule
NCT03353350Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
NCT03479073Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation
NCT04959305A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
NCT02444819Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy
NCT02940314Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers
NCT01491217A Study of Oraxol® in Gastric Cancer Patients
NCT02011633Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg
NCT01718847NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors
NCT04039724Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers
NCT01588145Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients
NCT02302443A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470
NCT03744182A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD
NCT04032782A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects
NCT00973115Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia
NCT07379333A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
NCT04081857A Study to Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects
NCT04762407A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
NCT05548387A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
NCT06595004A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
NCT02405065Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573
NCT01688193Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
NCT05481307A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203
NCT03332836Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
NCT01573663A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
NCT07660796A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
NCT04167553Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities
NCT01640535Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
NCT01013064A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects
NCT02057887Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A)
NCT01724814A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
NCT04324905Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers
NCT05422677An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
NCT01929070A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007
NCT02941679Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients
NCT01830491Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients
NCT07527650Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
NCT01455584Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors
NCT04829149Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT07205900Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
NCT04322266A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.
NCT03826641A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects
NCT04252872Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers
NCT04204629Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects
NCT02941796Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers
NCT01872182Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome